Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-08-28

FDA Approved: TYBOST — Supplemental Application (Gilead Sciences, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Tybost (cobicistat) submitted by Gilead Sciences, Inc., indicating an update to the product labeling following the s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tybost (Cobicistat)

Snippet

SUPPL AP for TYBOST (COBICISTAT)